Retrophin to Present at Upcoming Investor Conferences
August 03 2020 - 4:30PM
Retrophin, Inc. (NASDAQ: RTRX) today announced that Company
management will participate in the following upcoming virtual
investor conferences in August:
William Blair Biotech Focus Conference
2020Date: Thursday, August 6,
2020Time: 3:00 p.m. ET
Canaccord Genuity 40th Annual Growth
ConferenceDate: Wednesday, August 12,
2020Time: 2:00 p.m. ET
Live webcasts will be available at
http://ir.retrophin.com/events and archived replays will be
accessible for up to 30 days.
About Retrophin
Retrophin is a biopharmaceutical company
specializing in identifying, developing and delivering
life-changing therapies to people living with rare disease. The
Company’s approach centers on its pipeline featuring sparsentan, a
product candidate in late-stage development for focal segmental
glomerulosclerosis (FSGS) and IgA nephropathy (IgAN), rare
disorders characterized by progressive scarring of the kidney often
leading to end-stage renal disease. Research in additional rare
diseases is also underway, including partnerships with leaders in
patient advocacy and government research to identify potential
therapeutics for NGLY1 deficiency and Alagille syndrome, conditions
with no approved treatment options. Retrophin’s R&D efforts are
supported by revenues from the Company’s commercial products
Chenodal®, Cholbam®, Thiola® and Thiola EC®.
Retrophin.com
Contact:
Chris Cline, CFASenior Vice President, Investor Relations &
Corporate Communications888-969-7879IR@retrophin.com
Retrophin (NASDAQ:RTRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Retrophin (NASDAQ:RTRX)
Historical Stock Chart
From Apr 2023 to Apr 2024